These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27490860)

  • 41. Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands.
    Párraga J; Andujar SA; Rojas S; Gutierrez LJ; El Aouad N; Sanz MJ; Enriz RD; Cabedo N; Cortes D
    Eur J Med Chem; 2016 Oct; 122():27-42. PubMed ID: 27343851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.
    Kaczor AA; Silva AG; Loza MI; Kolb P; Castro M; Poso A
    ChemMedChem; 2016 Apr; 11(7):718-29. PubMed ID: 26990027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
    Peng X; Wang Q; Mishra Y; Xu J; Reichert DE; Malik M; Taylor M; Luedtke RR; Mach RH
    Bioorg Med Chem Lett; 2015 Feb; 25(3):519-23. PubMed ID: 25556097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors.
    Newton CL; Wood MD; Strange PG
    PLoS One; 2016; 11(7):e0158808. PubMed ID: 27379794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands.
    Salmas RE; Stein M; Yurtsever M; Seeman P; Erol I; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):2040-2048. PubMed ID: 27367058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: 2: effects of DAT inhibitors.
    Doudet DJ; Ruth TJ; Holden JE
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):28-37. PubMed ID: 15973354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors.
    Thomas T; Fang Y; Yuriev E; Chalmers DK
    J Chem Inf Model; 2016 Feb; 56(2):308-21. PubMed ID: 26690887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions.
    Salmas RE; Yurtsever M; Stein M; Durdagi S
    Mol Divers; 2015 May; 19(2):321-32. PubMed ID: 25652238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting G Protein-Coupled Receptors by Capture Compound Mass Spectrometry: A Case Study with Sertindole.
    Blex C; Michaelis S; Schrey AK; Furkert J; Eichhorst J; Bartho K; Gyapon Quast F; Marais A; Hakelberg M; Gruber U; Niquet S; Popp O; Kroll F; Sefkow M; Schülein R; Dreger M; Köster H
    Chembiochem; 2017 Aug; 18(16):1639-1649. PubMed ID: 28557180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.
    Ekhteiari Salmas R; Seeman P; Aksoydan B; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Apr; 8(4):826-836. PubMed ID: 28001043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ligand with Two Modes of Interaction with the Dopamine D
    Ågren R; Zeberg H; Stępniewski TM; Free RB; Reilly SW; Luedtke RR; Århem P; Ciruela F; Sibley DR; Mach RH; Selent J; Nilsson J; Sahlholm K
    ACS Chem Neurosci; 2020 Oct; 11(19):3130-3143. PubMed ID: 32865974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor.
    Sahlholm K; Zeberg H; Nilsson J; Ögren SO; Fuxe K; Århem P
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):467-76. PubMed ID: 26811292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists.
    Micheli F; Cremonesi S; Semeraro T; Tarsi L; Tomelleri S; Cavanni P; Oliosi B; Perdonà E; Sava A; Zonzini L; Feriani A; Braggio S; Heidbreder C
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1329-32. PubMed ID: 26786693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.
    Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K
    J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.